Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2438]

New metabolic signature predicts immunotherapy response and survival in cancer patients

New metabolic signature predicts immunotherapy response and survival in cancer patients

Researchers identify a novel biomarker linked to renal cancer recurrence

Researchers identify a novel biomarker linked to renal cancer recurrence

New urine test can improve accuracy for early detection of bladder cancer in patients with haematuria

New urine test can improve accuracy for early detection of bladder cancer in patients with haematuria

Study pinpoints cells that may drive treatment resistance in prostate cancer

Study pinpoints cells that may drive treatment resistance in prostate cancer

CAR T cell therapy for advanced prostate cancer demonstrates positive results in phase 1 clinical trial

CAR T cell therapy for advanced prostate cancer demonstrates positive results in phase 1 clinical trial

AI better detects prostate cancer on MRI than radiologists

AI better detects prostate cancer on MRI than radiologists

Glowing dye helps surgeons eradicate prostate cancer

Glowing dye helps surgeons eradicate prostate cancer

ASCO 2024: Innovative combination therapy shows promise for bladder cancer patients unresponsive to standard treatment

ASCO 2024: Innovative combination therapy shows promise for bladder cancer patients unresponsive to standard...

ASCO 2024: Prostate cancer spit test better for men with high genetic risk than standard blood test

ASCO 2024: Prostate cancer spit test better for men with high genetic risk than standard blood test

Risk of under-treatment and over-treatment in a group of Australian men diagnosed with prostate cancer

Risk of under-treatment and over-treatment in a group of Australian men diagnosed with prostate cancer

More from ecancer